Lake Vista Cancer Center

Lewisville, Texas 75067

0 studies enrolling now · 12 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Gastric Cancer Adenocarcinoma Metastatic, Hormone Refractory Prostate Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer, Prostate Cancer, Rectal Cancer

Studies at this site

• TAC Versus TC for Adjuvant Breast Cancer — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer — Completed
• Docetaxel+Oxali+/-Cetux Met Gastric/GEJ — Completed
• Adj TC + Herceptin Early Stage Breast Cancer — Completed
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer — Completed
• Pre-op Rectal ChemoRad +/- Cetuximab — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients — Completed
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early